InvestorsHub Logo
icon url

ash111

01/27/16 10:50 AM

#480 RE: exlud #479

05:40a ELEVEN BIOTHERAPEUTICS : Albumedix Acquires Albumin Variant Assets from Eleven B..
01/26 ELEVEN BIOTHERAPEUTICS : Albumedix and Eleven Biotherapeutics Announce Albumin V..

http://www.4-traders.com/ELEVEN-BIOTHERAPEUTICS-IN-15724816/news/Eleven-Biotherapeutics-Albumedix-Acquires-Albumin-Variant-Assets-from-Eleven-Biotherapeutics-21751150/
icon url

Johnnycash2013

01/27/16 10:53 AM

#481 RE: exlud #479

It's probably the best coarse of action to continue on the science as well as get some money for it. $1.07 per share in cash after all debt plus whatever $$$ this deal brought it could equal a very nice payday for anyone buying down here. Think we move north from here IMHO